Is moderate drinking actually good for you?

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

1. 1

   Association Between Daily Alcohol Intake and Risk of All-Cause Mortality

   JAMA Network Open (Zhao et al.)Published Mar 31, 2023Checked Sep 30, 2026

   “There were 724 risk estimates of all-cause mortality due to alcohol intake from the 107 cohort studies (4 838 825 participants and 425 564 deaths available) for the analysis. In models adjusting for potential confounding effects of sampling variation, former drinker bias, and other prespecified study-level quality criteria, the meta-analysis of all 107 included studies found no significantly reduced risk of all-cause mortality among occasional (>0 to <1.3 g of ethanol per day; relative risk [RR], 0.96; 95% CI, 0.86-1.06; P = .41) or low-volume drinkers (1.3-24.0 g per day; RR, 0.93; P = .07) compared with lifetime nondrinkers. In the fully adjusted model, there was a nonsignificantly increased risk of all-cause mortality among drinkers who drank 25 to 44 g per day (RR, 1.05; P = .28) and significantly increased risk for drinkers who drank 45 to 64 and 65 or more grams per day (RR, 1.19 and 1.35; P < .001). There were significantly larger risks of mortality among female drinkers compared with female lifetime nondrinkers (RR, 1.22; P = .03).”

2. 2

   Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

   The Lancet (Griswold et al.)Published Aug 23, 2018Checked Sep 30, 2026

   “Globally, alcohol use was the seventh leading risk factor for both deaths and DALYs in 2016, accounting for 2·2% (95% uncertainty interval [UI] 1·5-3·0) of age-standardised female deaths and 6·8% (5·8-8·0) of age-standardised male deaths. Among the population aged 15-49 years, alcohol use was the leading risk factor globally in 2016, with 3·8% (95% UI 3·2-4·3) of female deaths and 12·2% (10·8-13·6) of male deaths attributable to alcohol use. For the population aged 15-49 years, female attributable DALYs were 2·3% (95% UI 2·0-2·6) and male attributable DALYs were 8·9% (7·8-9·9). Alcohol use is a leading risk factor for global disease burden and causes substantial health loss. We found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero. These results suggest that alcohol control policies might need to be revised worldwide, refocusing on efforts to lower overall population-level consumption.”

3. 3

   Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease

   JAMA Network Open (Biddinger et al.)Published Mar 25, 2022Checked Sep 30, 2026

   “This study included 371 463 participants (mean [SD] age, 57.0 [7.9] years; 172 400 [46%] men), who consumed a mean (SD) 9.2 (10.6) standard drinks per week. Overall, 121 708 participants (33%) had hypertension. Light to moderate alcohol consumption was associated with healthier lifestyle factors, adjustment for which attenuated the cardioprotective epidemiologic associations with modest intake. In linear mendelian randomization analyses, a 1-SD increase in genetically predicted alcohol consumption was associated with 1.3-fold (95% CI, 1.2-1.4) higher risk of hypertension (P < .001) and 1.4-fold (95% CI, 1.1-1.8) higher risk of coronary artery disease (P = .006). Nonlinear mendelian randomization analyses suggested nonlinear associations between alcohol consumption and both hypertension and coronary artery disease: light alcohol intake was associated with minimal increases in cardiovascular risk, whereas heavier consumption was associated with exponential increases in risk of both clinical and subclinical cardiovascular disease. Conclusions and Relevance: In this cohort study, coincident, favorable lifestyle factors attenuated the observational benefits of modest alcohol intake.”

4. 4

   Moderate alcohol consumption and clinical outcomes in MASLD: a systematic review and meta-analysis of longitudinal cohorts.

   BMC gastroenterology (de et al.)Published Apr 30, 2026Checked Oct 4, 2026

   “Nine studies were selected for qualitative analysis, and seven were included in the meta-analysis. Effect measures, Hazard Ratios (HR) and Odds Ratios (OR), were pooled using Cochrane RevMan, and study quality was assessed with the Newcastle-Ottawa Scale.ProsperoCRD420261277466.ResultsThe meta-analysis showed no statistically significant association between moderate alcohol consumption and fibrosis progression (HR: 1.63 [95% CI: 0.96-2.77]; OR: 1.44 [95% CI: 0.56-3.72]). However, a statistically significant protective association was observed for all-cause mortality (HR: 0.73 [95% CI: 0.62-0.86]). High heterogeneity was noted across studies (I2 = 56.9-86.2%). Excessive alcohol consumption remained a strong risk factor for adverse outcomes, and the incidence of HCC significantly increased among patients with advanced fibrosis, even with light alcohol intake.ConclusionsEven moderate alcohol consumption may contribute to the progression of severe hepatic outcomes in SLD. These findings support clinical recommendations for total abstinence, particularly in patients with established fibrosis, to prevent progression to cirrhosis and hepatocellular carcinoma.”

5. 5

   Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions: A population-based cohort study in Korea.

   Addiction (Abingdon, England) (Bui et al.)Published Jul 1, 2026Checked Oct 4, 2026

   “9.89% (95% CI = 9.78-9.99) (0.4% difference). For diseases of the circulatory system (2 998 902 cases of ten subtypes), alcohol consumption was associated with increased risks of eight subtypes in men and two in women. In contrast, J- or U-shaped association was observed for ischemic heart diseases, heart failure (men) and cardiac arrhythmias (women), which was no longer evident in analyses using light drinking as the reference. Additionally, statistically significant positive association was exhibited in 14 other conditions among men and six among women. For mortality, alcohol consumption was associated with a lifetime incidence rate of death from any cause of 41.70% (95% CI = 41.40-42.01), compared with 39.06% (95% CI = 38.69-39.43) among current abstainers in men, a 2.6% difference. It was also associated with mortality from 15 diseases in men and nine in women.ConclusionsAlcohol consumption in Korea appears to be associated with numerous diseases and conditions, highlighting the need for strengthened national alcohol control policies. Protective effects of alcohol on cardiac health should be interpreted with caution.”

6. 6

   Alcohol, the Mediterranean Diet and Cardiovascular Risks: Where is the New Evidence?

   European cardiology (Martínez-González & Valdés-Mas)Published Sep 9, 2026Checked Oct 4, 2026

   “Traditionally, moderate wine consumption was considered part of the Mediterranean diet. However, whether low-to-moderate alcohol intake contributes independently to lower risk remains controversial. Early epidemiological reports supported a J-shaped association between alcohol intake and CVD, but residual confounding, selection biases or misclassification of former drinkers challenge causal interpretations. Methodological limitations, particularly the inability to capture drinking patterns, have also been raised in recent assessments of the Global Burden of Disease and Mendelian randomisation studies. A more nuanced view may be that low-to-moderate wine consumption in older adults is not likely to be harmful but alcohol should not be recommended for CVD prevention. Large-scale randomised trials, such as the ongoing UNATI study, are expected to clarify the impact of moderate drinking versus abstention. Meanwhile, clinical guidance should emphasise the proven cardiometabolic benefits of the Mediterranean diet overall independent of alcohol consumption.”

7. 7

   Health effects associated with alcohol consumption: a Burden of Proof study.

   Nature health (Dai et al.)Published Jun 1, 2026Checked Oct 4, 2026

   “Moreover, alcohol drinking guidelines vary widely. Here we conducted 16 systematic reviews across four databases and conservatively re-evaluated dose-response relationships between alcohol consumption and 20 health outcomes, analysing 843 cohort and case-control studies using the Burden of Proof meta-analytic framework. We found that levels of current alcohol consumption are associated with increased risks for cancers of the breast, colorectum, oesophagus, larynx, lip and oral cavities, pharynx, liver, stomach, pancreas and prostate, as well as pancreatitis, cirrhosis and other chronic liver diseases, lower respiratory infections, tuberculosis, and atrial fibrillation and flutter. We found J- or U-shaped relationships between alcohol consumption and type 2 diabetes, Alzheimer's disease and other dementias, ischaemic heart disease, ischaemic stroke and haemorrhagic stroke. While potential health impacts at low-to-moderate levels varied by outcome, high levels of alcohol consumption were associated with increased risk across all outcomes.”